AstraZeneca Drug Farxiga Shows Promise In Diabetic Patients
LONDON (Alliance News) - AstraZeneca PLC on Monday said the first sub-analyses from its phase three trial of Farxiga found it reduced the relative risk of major adverse cardiovascular events in a Read More